Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J no liability

This article was originally published in The Tan Sheet

Executive Summary

A California jury cleared McNeil Consumer & Specialty Pharmaceuticals on July 17 of liability in a lawsuit filed by 11-year-old Sabrina Brierton Johnson, who suffered Stevens-Johnson syndrome after using Children's Motrin. Johnson, who is now blind, will appeal her case, which alleges the Johnson & Johnson division failed to adequately warn on its product label that the ibuprofen in Motrin can trigger a rare allergic reaction that causes blindness and even death, according to lawyers at Greene Broillet & Wheeler, which represented the girl and her parents in the case litigated in Los Angeles Superior Court ("The Tan Sheet" June 16, 2008, p. 9)...

You may also be interested in...

Children’s Motrin Suit Seeks Compensation, New Label For Ibuprofen Product

A lawsuit that alleges Children's Motrin with ibuprofen caused a girl's blindness wants McNeil Consumer & Specialty Pharmaceuticals to clearly list all potential serious adverse reactions on the product's label and compensate the child

3D Carbon Partners With Resolution Medical To Produce More Than 1 Million Nasal Swabs A Week

Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.

ACC 2020: Medtronic’s Evolut TAVR Works In Low-Risk Bicuspid Study

Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts